Contrastingly, lipoprotein lipase (LPL) and suppressor of cytokine signaling (SOCS3) gene expressions were decreased (to 0.36 and 0.2-fold) by SCH treatment. The gene discussed is LPL; the disease is spindle cell hemangioma.